Gross margin moved 409 bp higher
Gross margin changed +409 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin changed +409 basis points from the comparable as-filed period.
Operating income changed +665.0% from the comparable as-filed period.
Operating margin changed +836 basis points from the comparable as-filed period.
Net income changed +347.4% from the comparable as-filed period.
Shares outstanding changed -1.4% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Revenue changed +25.6% from the comparable as-filed period.
Research & development changed +32.0% from the comparable as-filed period.
Trade receivables changed +23.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net debt changed +25.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +32.6% from the comparable as-filed period.
Free-cash-flow proxy changed +109.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash flow changed +125.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Cash / debt changed -1062 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed +222.2% from the comparable as-filed period.
Operating cash-flow margin changed +1780 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1664 basis points from the comparable as-filed period.
Debt / revenue changed -3201 basis points from the comparable as-filed period.
Cash & equivalents changed -7.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital changed +9.1% from the comparable as-filed period.
Total assets changed +2.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed +116 basis points from the comparable as-filed period.
Stock-based compensation changed +14.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed +149 basis points from the comparable as-filed period.
Receivables / revenue changed -170 basis points from the comparable as-filed period.
Stockholders' equity changed +3.5% from the comparable as-filed period.
Current liabilities changed +0.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current assets changed +5.1% from the comparable as-filed period.
R&D / revenue changed +104 basis points from the comparable as-filed period.
SBC / revenue changed -43 basis points from the comparable as-filed period.
Debt / assets changed -30 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed +4.4% from the comparable as-filed period.
Debt / equity changed -76 basis points from the comparable as-filed period.
Operating cash flow / net income changed +105.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Gross debt changed +0.6% from the comparable as-filed period.
Reported total debt changed +0.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.